Wendell Wierenga Cytokinetics Inc (CYTK) insider trading activity

Wendell Wierenga is Director of CYTOKINETICS INC. Currently has a direct ownership of 32,444 shares of CYTK, which is worth approximately $1.93 Million. The most recent transaction as insider was on Oct 27, 2025, when has been sold 4,375 shares (Common Stock) at a price of $58.68 per share, resulting in proceeds of $256,725. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.4K

n/a 3M change

n/a 12M change

Total Value Held $1.93 Million

WENDELL WIERENGA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 27 2025	SELL Open market or private sale	$256,725 $58.68 p/Share	4,375 Reduced 11.88%	32,444 Common Stock
Oct 27 2025	BUY Exercise of conversion of derivative security	$43,750 $10.0 p/Share	4,375 Added 10.62%	36,819 Common Stock
Oct 15 2025	BUY Grant, award, or other acquisition	$6,217 $62.8 p/Share	99 Added 0.3%	32,444 Common Stock

Also insider at

DRMA

Dermata Therapeutics, Inc. Healthcare